This report gives an insight into the global Gene Therapy Market and predicts the future growth prospects and the trends that may be exhibited in the market during the period of 2022-2029. The future growth has been calculated by taking into account the present growth rate and the overall market size. We have also discussed the alternatives that pose a threat to the growth of the market. In, this report we have categorized the global Gene Therapy Market into segments that are: Vector Type (Viral Vector, Non-Viral Vector); By Therapy (In Vivo Therapy, Ex Vivo Therapy); By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others); By Application (Oncological Disorders, Rare Diseases, Neurological Disorders, Other Diseases); By Region (North America, Asia Pacific, Europe, Latin America, Middle East, and Africa)
We have also illustrated the vendor landscape and conducted a detailed analysis of the top five global vendors of the global Gene Therapy Market. The report also presents an analysis of the drivers that enable the growth of the market, the key challenges faced by the vendors and the market as a whole, and the upcoming trends that can have an impact on the market.
Marketlook Consulting has collected key data related to the global Gene Therapy Market and analyzed these data using a variety of methods. The market dynamics have been ascertained following a detailed study of the micro, meso and microeconomic indicators in the market. The report is based on in-depth qualitative and quantitative analyses of the global Gene Therapy Market. The qualitative analysis involved the application of various projection and sampling techniques. The qualitative analysis involved primary interviews, surveys and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions.
Global Gene Therapy Market Would Cross USD 17.2 Bn By 2029
Global Gene Therapy Market report provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for sports medicine solution providers across the Globe. This report on the global Gene Therapy Market studies the past as well as the current growth trends and opportunities to gain valuable insights into the indicators of the market during the forecast period from 2022 to 2029. The report provides revenue of the global sports medicine for the period 2019-2029, considering 2021 as the base year and 2022-29 as the forecast year. The report also provides the compound annual growth rate (CAGR 18.0%) of the global sports medicine from 2022 to 2029.
Segmental Analysis of global Gene Therapy Market Study
The global Gene Therapy Market study is segmented based on the various parameters by identifying their business activities, geographical presence, key application areas, end-users, etc., The report covers the market share analysis of all the segments from the year 2022-2029. From a strategic point of view, the market outlook covers several frameworks including SWOT Analysis, Value Chain Analysis, and Porter's Five Forces Analysis while also offering an evaluation of the Vector Type/Market Lifecycle.
Geographical Coverage of the global Gene Therapy Market Study
For a better understanding of the global sports medicine market is segmented into geographies such as the North America (U.S, Canada), Europe (U.K, France, Germany, Russia, Italy, Rest of Europe), Asia Pacific (China, Japan, India, Australia, South-Korea, Rest of APAC), Latin America (Brazil, Mexico, Rest of Latin America), Middle East and Africa (Saudi Arabia, The U.A.E, South Africa, Rest of MEA). The country-level analysis in each region is also provided in very exhaustive manner.
Company Analysis on the global Gene Therapy Market Study
In the report, the degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysis sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative Vector Type launches, partnerships, mergers and acquisitions by leading company in the market. The major players have been analyzed by using research methodologies for getting insight views on global competition.
Table of Content:
1. Introduction
1.1. Research Objective
1.2. Research Methodology
1.3. Research Process
1.4. Respondent Profile
2. Executive Summary
3. Global Gene Therapy Market Outlook, 2019-2029F
3.1. Market Size & Analysis
3.2. Market Share & Analysis
3.2.1. By Vector Type
3.2.1.1 Viral Vector
3.2.1.2 Non-Viral Vector
3.2.2. By Therapy
3.2.2.1 In-Vivo Therapy
3.2.2.2 Ex Vivo Therapy
3.2.3. By Gene Type
3.2.3.1. Antigen
3.2.3.2. Cytokine
3.2.3.3. Tumor Suppressor
3.2.3.4. Suicide
3.2.3.5. Deficiency
3.2.3.6. Growth factors
3.2.3.7. Receptors
3.2.3.8. Others
3.2.4. By Application
3.2.4.1. Oncological Disorders
3.2.4.2. Rare Diseases
3.2.4.3. Neurological Disorders
3.2.4.4. Other Diseases
3.2.5. By Region
3.2.5.1. Asia-Pacific
3.2.5.2. Europe
3.2.5.3. North America
3.2.5.4. Middle East & Africa
3.2.5.5. Latin America
4. Asia-Pacific Gene Therapy Market Outlook, 2019-2029F
4.1. Market Size & Analysis
4.2. Market Share & Analysis
4.2.1. By Vector Type
4.2.2. By Therapy
4.2.3. By Gene Type
4.2.4. By Application
4.2.5. By Country
4.2.5.1. China
4.2.5.2. India
4.2.5.3. Japan
4.2.4.4. South Korea
4.2.5.5. Australia
4.2.5.6. Rest of Asia-Pacific
5. Europe Gene Therapy Market Outlook, 2019-2029F
5.1. Market Size & Analysis
5.2. Market Share & Analysis
5.2.1. By Vector Type
5.2.2. By Therapy
5.2.3. By Gene Type
5.2.4. By Application
5.2.5. By Country
5.2.5.1. United Kingdom
5.2.5.2. Germany
5.2.5.3. France
5.2.5.4. Italy
5.2.5.5. Russia
5.2.5.6. Rest of Europe
6. North America Gene Therapy Market Outlook, 2019-2029F
6.1. Market Size & Analysis
6.2. Market Share & Analysis
6.2.1. By Vector Type
6.2.2. By Therapy
6.2.3. By Gene Type
6.2.4. By Application
6.2.5. By Country
6.2.5.1. United States
6.2.5.2. Canada
7. Latin America Gene Therapy Market Outlook, 2019-2029F
7.1. Market Size & Analysis
7.2. Market Share & Analysis
7.2.5. By Vector Type
7.2.5. By Therapy
7.2.4. By Gene Type
7.2.5. By Application
7.2.5. By Country
7.2.5.1. Brazil
7.2.5.2. Mexico
7.2.5.3. Rest of Latin America
8. Middle East & Africa Gene Therapy Market Outlook, 2019-2029F
8.1. Market Size & Analysis
8.2. Market Share & Analysis
8.2.1. By Vector Type
8.2.2. By Therapy
8.2.3. By Gene Type
8.2.4. By Application
8.2.5. By Country
8.2.5.1. Saudi Arabia
8.2.5.2. UAE
8.2.5.3. South Africa
8.2.5.4. Rest of Middle East and Africa
9. Global Gene Therapy Market Dynamics
9.1. Growth Drivers
9.2. Challenges
9.3. Impact Analysis
10. Global Gene Therapy Market Opportunities
11. Global Sports Medicine Value Chain Analysis
12. Global Gene Therapy Market Policies and Regulations
13. Global Gene Therapy Market Trends & Insights
14. Global Gene Therapy Market Porters Five Forces Analysis
15. Global Gene Therapy Market-Entropy
15.1. New Vector Type Launches
15.2. M&A, Collaborations, JVs, and Partnerships
16. Global Gene Therapy Market Company Analysis
16.1. Amgen Inc.
16.2 Biogen Inc.
16.3 Bluebird Bio Inc.
16.4 Gilead Sciences Inc. (Kite Pharma)
16.5 Novartis AG
16.6 F. Hoffmann-La Roche Ltd (Spark Therapeutics)
16.7 UniQure NV
16.8 Abeona Therapeutics Inc.
16.9 Generation Bio
16.10 Poseida Therapeutics
17. About Us & Contact Details
The Gene Knockdown Stable Cell Line Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Gene Knockdown Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturer...
The Gene Editing Technology Innovation Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The CD19-targeted CAR-T Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Osteoarthritis Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Cell Therapy Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
The Cell and Gene Therapy Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The PPMO (Peptide-PMO Conjugates) Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Hip Pain Therapy Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Microbial Gene Editing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...